Patents by Inventor Gregory Zarbis-Papastoitsis

Gregory Zarbis-Papastoitsis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20220339284
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: December 15, 2021
    Publication date: October 27, 2022
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20210260186
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: February 9, 2021
    Publication date: August 26, 2021
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Purified antibody composition
    Patent number: 11083792
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: August 10, 2021
    Assignee: AbbVie Biotechnology Ltd
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Chimeric cytokine formulations for ocular delivery
    Patent number: 10799589
    Abstract: Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: October 13, 2020
    Assignee: BUZZARD PHARMACEUTICALS AB
    Inventors: Gregory Zarbis-Papastoitsis, Patricia Lowden, Byeong Chang
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20190298829
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: November 8, 2018
    Publication date: October 3, 2019
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY
    Publication number: 20180177877
    Abstract: Featured herein are vehicle formulations and formulations containing a chimeric cytokine designed for e.g., ocular delivery.
    Type: Application
    Filed: August 7, 2017
    Publication date: June 28, 2018
    Inventors: Gregory Zarbis-Papastoitsis, Patricia Lowden, Byeong Chang
  • Purified antibody composition
    Patent number: 9913902
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: September 28, 2017
    Date of Patent: March 13, 2018
    Assignee: ABBVIE BIOTECHNOLOGY LTD.
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20180036407
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: September 28, 2017
    Publication date: February 8, 2018
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20170136122
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: June 7, 2016
    Publication date: May 18, 2017
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Purified antibody composition
    Patent number: 9328165
    Abstract: The invention provides a method for producing a host cell protein—(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: May 3, 2016
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Purified antibody composition
    Patent number: 9273132
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: March 1, 2016
    Assignee: AbbVie Biotechnology Ltd
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20150361168
    Abstract: The invention provides a method for producing a host cell protein—(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: August 31, 2015
    Publication date: December 17, 2015
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20150361169
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: August 31, 2015
    Publication date: December 17, 2015
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20150307605
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: July 10, 2015
    Publication date: October 29, 2015
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Purified antibody composition
    Patent number: 9102723
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: August 11, 2015
    Assignee: AbbVie Biotechnology Ltd
    Inventors: Min M Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Purified antibody composition
    Patent number: 9096666
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: August 4, 2015
    Assignee: AbbVie Biotechnology Ltd
    Inventors: Min M Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20150079103
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 19, 2015
    Inventors: Min M Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • PURIFIED ANTIBODY COMPOSITION
    Publication number: 20150079102
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 19, 2015
    Inventors: Min M Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Purified antibody composition
    Patent number: 8916153
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: June 26, 2013
    Date of Patent: December 23, 2014
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Min M. Wan, George Avgerinos, Gregory Zarbis-Papastoitsis
  • Purified antibody composition
    Patent number: 8906372
    Abstract: The invention provides a method for producing a host cell protein-(HCP) reduced antibody preparation from a mixture comprising an antibody and at least one HCP, comprising an ion exchange separation step wherein the mixture is subjected to a first ion exchange material, such that the HCP-reduced antibody preparation is obtained.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: December 9, 2014
    Assignee: AbbVie Biotechnology Ltd.
    Inventors: Min Wan, George Avgerinos, Gregory Zarbis-Papastoitsis